FDA Grants Accelerated Approval To First Gene Therapy For Duchenne Muscular Dystrophy
June 23, 2023
MedPage Today (6/22, George) reports, “The FDA granted accelerated approval to delandistrogene moxeparvovec (Elevidys), the first gene therapy for Duchenne muscular dystrophy” (DMD), “the agency announced” in a June 22 news release on its website. This “a...